Qiagen

Qiagen

QGENPre-clinical
Venlo, NetherlandsFounded 1984qiagen.com

QIAGEN operates as a Sample to Insight company, providing integrated solutions that transform biological samples into valuable molecular insights. With a focus on molecular diagnostics and life sciences research, the company serves clinical laboratories, academic institutions, pharmaceutical and biotechnology companies worldwide. QIAGEN's product portfolio spans the entire sample-to-insight workflow, from sample collection and preparation to assay development, automation, and data analysis. The company is publicly traded on NASDAQ under the ticker QGEN and is headquartered in the Netherlands.

Market Cap
$8.2B
Founded
1984
Focus
AntibodiesDiagnostics

QGEN · Stock Price

USD 39.939.62 (-19.41%)

Historical price data

AI Company Overview

QIAGEN operates as a Sample to Insight company, providing integrated solutions that transform biological samples into valuable molecular insights. With a focus on molecular diagnostics and life sciences research, the company serves clinical laboratories, academic institutions, pharmaceutical and biotechnology companies worldwide. QIAGEN's product portfolio spans the entire sample-to-insight workflow, from sample collection and preparation to assay development, automation, and data analysis. The company is publicly traded on NASDAQ under the ticker QGEN and is headquartered in the Netherlands.

Technology Platform

Comprehensive Sample to Insight platform providing integrated solutions from sample preparation through assay development, automation, and data analysis for molecular diagnostics and life sciences research applications.

Opportunities

QIAGEN is well-positioned to capitalize on the growing molecular diagnostics market, increasing laboratory automation trends, and expansion of precision medicine applications.
The company's comprehensive Sample to Insight platform and strong consumables business model provide multiple growth avenues across diagnostics and research markets.

Risk Factors

Key risks include intense competition from larger players like Thermo Fisher and Roche, potential technology disruption, evolving regulatory requirements for diagnostic products, and dependence on healthcare spending and research funding patterns.
Supply chain complexity across global operations also presents operational risks.

Competitive Landscape

QIAGEN competes with major players including Thermo Fisher Scientific, Roche Diagnostics, Abbott, and Illumina across different product categories. The company differentiates through its integrated Sample to Insight approach and focus on comprehensive workflow solutions rather than standalone instruments, though faces pressure from larger, more diversified competitors.

Publications
20
Patents
20

Company Info

TypeDiagnostics
Founded1984
LocationVenlo, Netherlands
StagePre-clinical
RevenueRevenue Generating

Trading

TickerQGEN
ExchangeNASDAQ

Contact

Therapeutic Areas

Infectious DiseaseOncologyMolecular DiagnosticsHuman IdentificationForensics

Partners

Parse Biosciences
SIMILAR COMPANIES
2-BBB Medicines
2-BBB Medicines
Pre-clinical · Leiden
Batavia Biosciences
Batavia Biosciences
Pre-clinical · Leiden
Bilthoven Biologicals
Bilthoven Biologicals
Pre-clinical · Bilthoven
Agendia
Agendia
Pre-clinical · Amsterdam
Alloksys Life Sciences
Alloksys Life Sciences
Phase 2 · Wageningen
Is this your company?

Claim your profile to update information, add pipeline data, and connect with investors.

Claim profile